Magazine Article | February 1, 2019

Why 2018 Was The Year Of Real-World Evidence For Biosimilars

Source: Life Science Leader

By Anna Rose Welch, Editorial & Community Director, Advancing RNA

In 2018, it became clear to me that the biosimilar industry had taken the need for real-world evidence (RWE) to heart. At a conference in Brazil in August, I was asked to present on the RWE efforts I felt were particularly notable. In doing the research for this presentation, my eyes were opened to the pace at which biosimilar evidence is being released.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader